Eleni I Capetanakis M D - 91911 Chula Vista, CA

Business Name: Eleni I Capetanakis M D
Categorized In: Physicians Offices
Address: 865 3rd Avenue # 101, Chula Vista, CA 91911
Phone Number: (619) 426-7910
Contact Person: Eleni I Capetanakis
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2004
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Eugene J Basiliere M D - Chula Vista, CA 91911
Xray Medical Group Radiation Oncology - Chula Vista, CA 91911
Hamedaninia Azardokht MD - Chula Vista, CA 91911
James Stokos Md - Chula Vista, CA 91911
Tiznado-Garcia Ernesto MD - Chula Vista, CA 91911
Lance L Altenau M D - Chula Vista, CA 91911
Chu Neelina V MD - Chula Vista, CA 91911
Sharp Hospital - Chula Vista, CA 91911
Lance Altenau Md - Chula Vista, CA 91911
Kurosu Catherine J MD - Chula Vista, CA 91911
Cordoba Miguel MD - Chula Vista, CA 91911
Prabhu Ravindra MD - Chula Vista, CA 91911
Chang Irene MD - Chula Vista, CA 91911
Desta Taddese M D - Chula Vista, CA 91911
Md Tim Dabfm Gurtch - Chula Vista, CA 91911
Avila Patricia M D - Chula Vista, CA 91911
Robert L Martin Dr - Chula Vista, CA 91911
Gastroenterology Associates - Chula Vista, CA 91911
Dr Burquez - Chula Vista, CA 91911
Irene S Fu M D - Chula Vista, CA 91911

Eleni I Capetanakis M D provides professional Physicians Offices from its single location at the coordinates 32.621876,-117.072113.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2004, the company can now be visited at 865 3rd Avenue # 101, Chula Vista, California 91911 or contacted through representative Eleni I Capetanakis at (619) 426-7910.

For frequently asked questions and further inquiries about professional Physicians Offices, get to know more about Eleni I Capetanakis M D through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.